Paratek Pharmaceuticals, Inc. (34) | Uncategorized (10)
Recent Contracts
-
Paratek Pharmaceuticals, Inc. 2017 Inducement Plan, as amended
(Filed With SEC on March 14, 2022)
-
Amendment No. 4 to the Product Agreement, by and between the Company and Patheon UK Limited, dated as of November 17, 2021
(Filed With SEC on March 14, 2022)
-
Amendment No. 2 to the Product Agreement, by and between the Company and Patheon UK Limited, dated as of June 1, 2019
(Filed With SEC on January 4, 2021)
-
Amendment No. 3 to the Product Agreement, by and between the Company and Patheon UK Limited, dated as of July 1, 2020
(Filed With SEC on January 4, 2021)
-
Description of Securities
(Filed With SEC on March 10, 2020)
-
Amended and Restated Employee Agreement for Michael F. Bigham effective June 25, 2019
(Filed With SEC on August 6, 2019)
-
Amended and Restated Employee Agreement for Evan Loh, MD, effective June 25, 2019
(Filed With SEC on August 6, 2019)
-
Amended and Restated Employee Agreement for Adam Woodrow effective June 25, 2019
(Filed With SEC on August 6, 2019)
-
Amendment Agreement - Amendment No. 1 to Patheon Product Agreement by and between the Company and Patheon UK Limited dated as of January 1, 2019
(Filed With SEC on May 8, 2019)
-
First Amendment of Outsourcing Agreement, by and between the Company and CARBOGEN AMCIS AG, dated as of December 18, 2018
(Filed With SEC on March 6, 2019)